Highlights
TSX: TKM       Tekmira Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):0
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing ribonucleic acid (RNA) interference (RNAi) therapeutics and providing its lipid nanoparticle (LNP) delivery technology to pharmaceutical and biotechnology partners. Its product candidates include TKM-HBV, TKM-PLK1, TKM-Ebola and TKM-Marburg. TKM-HBV is an RNAi therapeutic for the treatment of Hepatitis B infection. The Company's lead oncology product candidate, TKM -PLK1 is an oncology product platform that targets polo-like kinase 1 (PLK1), a protein involved in tumor cell proliferation and a validated oncology target. TKM-ALDH2 is an application of RNAi for alcohol use disorder with a target patient population who have moderate to severe alcohol use disorder. TKM-Ebola is an anti-Ebola viral therapeutic being developed under a contract with the United States Department of Defense Joint Project Manager Medical Countermeasure Systems. TKM-Marburg is used to treat hemorrhagic fever viral infections.

  Be the first to like this.
 


 

799  763  1303  1681 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ENB 51.37+0.70 
 MFC 26.26-0.12 
 ECA 5.86-0.11 
 K 5.65-0.03 
 ACB 4.69-0.02 
 ABX 22.08+0.33 
 GOOS 46.13-5.65 
 VUL 0.105+0.025 
 OGI 3.33-0.24 
 YRI 4.52+0.09 
Partners & Brokers